Oscar krijgsman
Oscar krijgsman
Principle Bioinformatician, Neogene Therapeutics
Verified email at
Cited by
Cited by
B cells and tertiary lymphoid structures promote immunotherapy response
BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ...
Nature 577 (7791), 549-555, 2020
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
J Müller, O Krijgsman, J Tsoi, L Robert, W Hugo, C Song, X Kong, ...
Nature communications 5 (1), 1-15, 2014
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
CU Blank, EA Rozeman, LF Fanchi, K Sikorska, B van de Wiel, ...
Nature medicine 24 (11), 1655-1661, 2018
Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases
F Weeber, M van de Wetering, M Hoogstraat, KK Dijkstra, O Krijgsman, ...
Proceedings of the National Academy of Sciences 112 (43), 13308-13311, 2015
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2 …
EA Rozeman, AM Menzies, ACJ van Akkooi, C Adhikari, C Bierman, ...
The Lancet Oncology 20 (7), 948-960, 2019
CopywriteR: DNA copy number detection from off-target sequence data
T Kuilman, A Velds, K Kemper, M Ranzani, L Bombardelli, M Hoogstraat, ...
Genome biology 16 (1), 1-15, 2015
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors
J Boshuizen, LA Koopman, O Krijgsman, A Shahrabi, EG van den Heuvel, ...
Nature medicine 24 (2), 203-212, 2018
Focal aberrations indicate EYA2 and hsa‐miR‐375 as oncogene and tumor suppressor in cervical carcinogenesis
M Bierkens, O Krijgsman, SM Wilting, L Bosch, A Jaspers, GA Meijer, ...
Genes, Chromosomes and Cancer 52 (1), 56-68, 2013
A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response
O Krijgsman, P Roepman, W Zwart, JS Carroll, S Tian, FA de Snoo, ...
Breast cancer research and treatment 133 (1), 37-47, 2012
Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy
K Renner, C Bruss, A Schnell, G Koehl, HM Becker, M Fante, ...
Cell reports 29 (1), 135-150. e9, 2019
Intra‐and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts
K Kemper, O Krijgsman, P Cornelissen‐Steijger, A Shahrabi, F Weeber, ...
EMBO molecular medicine 7 (9), 1104-1118, 2015
TSPYL5 suppresses p53 levels and function by physical interaction with USP7
MT Epping, LAT Meijer, O Krijgsman, JL Bos, PP Pandolfi, R Bernards
Nature cell biology 13 (1), 102-108, 2011
Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold
DW Vredevoogd, T Kuilman, MA Ligtenberg, J Boshuizen, KE Stecker, ...
Cell 178 (3), 585-599. e15, 2019
Microarray-Based Determination of Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Status in Breast CancerMicroarray Readout of ER, PR, and HER2
P Roepman, HM Horlings, O Krijgsman, M Kok, JM Bueno-de-Mesquita, ...
Clinical Cancer Research 15 (22), 7003-7011, 2009
Transcription factor NFIB is a driver of small cell lung cancer progression in mice and marks metastatic disease in patients
EA Semenova, M Kwon, K Monkhorst, JY Song, R Bhaskaran, ...
Cell reports 16 (3), 631-643, 2016
PRAME expression and clinical outcome of breast cancer
MT Epping, AAM Hart, AM Glas, O Krijgsman, R Bernards
British journal of cancer 99 (3), 398-403, 2008
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
EA Rozeman, EP Hoefsmit, ILM Reijers, RPM Saw, JM Versluis, ...
Nature Medicine 27 (2), 256-263, 2021
Integrative epigenetic taxonomy of primary prostate cancer
S Stelloo, E Nevedomskaya, Y Kim, K Schuurman, E Valle-Encinas, ...
Nature communications 9 (1), 1-12, 2018
High lymph node yield is related to microsatellite instability in colon cancer
EJ Belt, EA te Velde, O Krijgsman, RP Brosens, M Tijssen, HF van Essen, ...
Annals of surgical oncology 19 (4), 1222-1230, 2012
Gene‐dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression
FLM de Groen, O Krijgsman, M Tijssen, LEM Vriend, B Ylstra, E Hooijberg, ...
Genes, Chromosomes and Cancer 53 (4), 339-348, 2014
The system can't perform the operation now. Try again later.
Articles 1–20